5%+ stake

Tenax Therapeutics (TENX): RTW Investments, LP cut its TENX stake below 5% (0%) 0.0%

RTW Investments, LP cut its TENX stake below 5% (0%).

0.0%
Stake
Stake as of
Sep 30, 2026
Filed
Nov 16, 2026

What stands out in this filing

  • Reported stake 0.0%.
  • The filing reports the stake below 5%, the level at which these reports stop being required.
  • A 13G is the short form for a passive owner of more than 5%.

Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Aug 20, 2026Insider · Largest insider buy since 201010% owner purchased ~$360K of TENX shares in the open market
  2. Aug 21, 2026Insider · Largest insider buy since 201010% owner purchased ~$1.27M of TENX shares in the open market
  3. Aug 24, 2026Insider10% owner purchased ~$188K of TENX shares in the open market
  4. Aug 31, 2026Insider10% owner purchased ~$723K of TENX shares in the open market
  5. Sep 1, 2026Insider10% owner purchased ~$322K of TENX shares in the open market
  6. Sep 2, 2026Insider10% owner purchased ~$338K of TENX shares in the open market
  7. Sep 3, 2026Insider · Largest insider buy since 201010% owner purchased ~$1.6M of TENX shares in the open market
  8. Sep 11, 2026Insider · 2 peopleInsiders: 2 purchases (~$22K)
  9. Sep 15, 2026InsiderCEO purchased ~$8.8K of TENX shares in the open market
  10. Sep 16, 2026Insider · 3 insiders in a week, 2nd time since 2010Director purchased ~$102K of TENX shares in the open market

What came next

  1. Oct 13, 20265% stakeSphera Funds Management Ltd. reported a passive stake (13G) of 7.1%
  2. Oct 15, 20265% stakeMillennium Management LLC reported a passive stake (13G) of 3.6%
  3. Oct 19, 2026Insider10% owner purchased ~$507K of TENX shares in the open market
  4. Oct 20, 2026Insider10% owner purchased ~$406K of TENX shares in the open market
  5. Oct 21, 2026Insider10% owner purchased ~$551K of TENX shares in the open market
  6. Oct 27, 20265% stakeBlackRock, Inc. reported a passive stake (13G) of 7.5%
  7. Nov 5, 2026Company filing · Form 8-K · ResultsReported its results
  8. Nov 12, 20265% stakeAdage Capital Management, L.P. reported a passive stake (13G) of 2.3%
  9. Nov 16, 20265% stakeADAR1 Capital Management, LLC reported a passive stake (13G) of 16.4%
  10. Nov 16, 20265% stakeRTW Investments, LP reported a passive stake (13G)
  11. Nov 16, 20265% stakeSirenia Capital Management LP reported a passive stake (13G) of 5.4%
  12. Nov 16, 20265% stakeJANUS HENDERSON GROUP Ltd. reported a passive stake (13G)
  13. Nov 16, 20265% stakeVestal Point Capital, LP reported a passive stake (13G)
  14. Nov 16, 20265% stakeBVF PARTNERS L P/IL reported a passive stake (13G) of 10.0%
View the official recordSEC Schedule 13G

How to read SEC Schedule 13G

A Schedule 13D and a Schedule 13G both disclose beneficial ownership of more than 5% of a US company's voting shares. A 13D is the long form, filed by holders who may seek to influence or control the company, and it must state what they intend to do. A 13G is the short form, open only to passive holders and to certain institutions holding in the ordinary course of business, and it asks no question about intent.

Full guide: Schedule 13D vs Schedule 13G: what is the difference?

What else is on file for Tenax Therapeutics

For Tenax Therapeutics, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its TENX page.

How this filing works

Explore the data

Common questions

What does this filing report about Tenax Therapeutics (TENX) stock?

RTW Investments, LP cut its TENX stake below 5% (0%). Of the company, Schedule 13G (passive).

When did it happen, and when was it made public?

Stake as of: Sep 30, 2026. Filed: Nov 16, 2026.

What stands out in this filing?

Reported stake 0.0%. The filing reports the stake below 5%, the level at which these reports stop being required. A 13G is the short form for a passive owner of more than 5%.

Is this a trade made on a known date?

No. A holdings report is a picture of the portfolio on the last day of the quarter. It shows what was held on that day, not the day or the price at which anything was bought or sold.

Where does this information come from?

From the SEC Schedule 13G, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.

What else has been disclosed about Tenax Therapeutics recently?

For Tenax Therapeutics, OQRO holds 14 insider filings (SEC Form 4 or Form 144) and 6 fund holdings reports (13F) dated in the last 90 days. They are listed on the TENX page.

Does this mean TENX stock is a buy or a sell?

No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.

Is OQRO free?

Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.

Other disclosures at Tenax Therapeutics

Everything OQRO holds on this company is on its TENX page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO is free for everyone. No card, no trial

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data